Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: A randomized, double blind, parallel-controlled study versus tibolone

Maturitas

Volumn 58, Issue 1, 2007, Pages 31-41

  Bai, Wenpei ^a   Henneicke von Zepelin, Hans Heinrich ^b   Wang, Shuyu ^c   Zheng, Shurong ^a   Liu, Jianli ^d   Zhang, Zhonglan ^d   Geng, Li ^e   Hu, Lina ^f   Chunfeng, Jiao ^g   Liske, Eckehard ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Schaper & Brummer GmbH & Co KG   (Germany)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^e PEKING UNIVERSITY THIRD HOSPITAL   (China)

^f SICHUAN UNIVERSITY   (China)

^g Biometrical Department   (China)

Author keywords

Black cohosh; Menopausal symptom; Tibolone

Indexed keywords

2 PROPANOL; CIMICIFUGA RACEMOSA EXTRACT; ESTRADIOL; FOLLITROPIN; PLACEBO; TIBOLONE; UNCLASSIFIED DRUG; ZI ZHU AWEI;

ABDOMINAL PAIN; ADULT; ARTICLE; CHINESE MEDICINE; CIMICIFUGA RACEMOSA; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDEMA; FEMALE; HERBAL MEDICINE; HUMAN; LEUKORRHEA; LIVER TOXICITY; MASTALGIA; MENOPAUSAL SYNDROME; MENOPAUSE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TRADITIONAL MEDICINE; TREATMENT OUTCOME; VAGINA BLEEDING;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CIMICIFUGA; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ESTROGEN RECEPTOR MODULATORS; FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; METRORRHAGIA; MIDDLE AGED; NORPREGNENES; ODDS RATIO; PHYTOESTROGENS; PHYTOTHERAPY; PLANT EXTRACTS; STATISTICS, NONPARAMETRIC;

CIMICIFUGA DAHURICA; CIMICIFUGA RACEMOSA;

EID: 34547952205     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.04.009     Document Type: Article

References (43)

1. Boulet M.J., Oddens B.J., Lehert P., Vemer H.M., and Visser A. Climacteric and menopause in seven South-east Asian countries. Maturitas 19 3 (1994) 157-176
2. Nik N.I. Menopause and HRT in Malaysia. In: Ratnam S.S., and Campana A. (Eds). First consensus meeting on menopause in the East Asian Region (1998), Medical Forum International, The Netherlands 197-204
3. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynaecological disorders. Adv Ther 15 (1998) 45-53
4. Nappi R.E., Malavasi B., Brundu B., and Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 20 1 (2005) 30-35
5. Osmers R., Friede M., Liske E., Schnitker J., Freudenstein J., and Henneicke-von Zepelin H.H. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 105 (2005) 1074-1083
6. Uebelhack R., Blohmer J.U., Graubaum H.J., Busch R., Grünwald J., and Wernecke K.D. Black Cohosh and St. John's Wort for Climacteric Complaints. Obstet Gynecol 107 2 (2006) 247-255
7. Stoll W. Phytotherapeutikum beeinflusst atrophische Vaginalepithel. Therapeutikon 1 (1987) 23-31
8. Low Dog T., Powell K.L., and Weisman S.M. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 10 (2003) 299-313
9. Geller S.E., and Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health 14 (2005) 634-649
10. Egarter C., Huber J., Leikermoser R., Haidbauer R., Pusch H., Fischl F., et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 23 (1996) 55-62
11. Bai W., Yang X., Zheng S., et al. Clinical study of domestic tibolone in the treatment of menopausal syndrome. Chin J Clin Pharmacol 17 4 (2001) 252-256
12. Wei L.J., and Lachin J.M. Two-sample asymptotically distribution-free test for incomplete multivariate observations. J Am Stat Assoc 79 (1984) 653-661
13. Osmers R., and Kraft K. Phytotherapy in menopausal symptoms. Pharm Unserer Zeit 33 (2004) 384-391 [in German]
14. Wuttke W., Seidlova-Wuttke D., and Gorkow C. The Cimicifuga preparation BNO 1055 versus conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44 (2003) 867-877
15. Pockaj B., Gallagher J., Loprinzi C., Stella P., Barton D., Sloan J., et al. Phase III double-blind, randomized, placebo-controlled clinical crossover trial of black cohosh in the management of hot flashes: NCCTG trial N01CC. J Clin Oncol 24 (2006) 2836-2841
16. Jacobson J.S., Troxel A.B., Evans J., et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 19 (2001) 2739-2745
17. Frei-Kleiner S., Schaffner W., Rahlfs V.W., Bodmer C., and Birkhäuser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 51 (2005) 397-404
18. Bischoff M. Wechseljahre: Pflanzliche Alternativen auf dem Prüfstand. Gynäkologie 3/2005.
19. Lehmann-Willenbrock E., and Riedel H.H. Klinische und endokrinologische Untersuchungen zur Therapie ovarieller Ausfallserscheinungen nach Hysterektomie unter Belassung der Adnexe. Zentralbl Gynakol 110 (1988) 611-618
20. Newton K.M., Reed S.D., LaCroix A.Z., Grothaus L.C., Ehrlich K., and Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. A. randomized trial. Ann Intern Med 145 (2006) 869-879
21. American Botanical Council. Black Cohosh clinical trial not representative of previous research showing positive results. Press release, Austin, TX, December 21, 2006.
22. Kaeufeler RE. Are conclusions of the HALT-study on herbal remedy really sound? Ann Intern Med, Electronic letters published January 19, 2007.
23. Raus K., Brucker C., Gorkow C., and Wuttke W. First-time proof of endometrial safety of the special black cohosh extract (Actea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 13 (2006) 678-691
24. Viereck V., Emons G., and Wuttke W. Black cohosh: just another phytoestrogen?. Trends Endocrinol Metab 16 5 (2005) 214-221
25. In: Roy Upton Herbalist (Ed). American herbal pharmacopoeia and therapeutic compendium: black cohosh rhizome (2002), AHP, Santa Cruz (CA)
26. Nisslein T., and Freudenstein J. Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. J Bone Miner Metab 21 (2003) 370-376
27. Hirschberg A.L., Edlund M., Svane G., Azavedo E., Skoog L., and von Schoultz B. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause 14 1 (2007) 89-96
28. Henneicke-von Zepelin H.-H., Meden H., Kostev K., Schröder-Bernhardi D., Stammwitz U., and Becher H. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther 45 3 (2007) 143-154
29. Reame N, Eyvazzadeh A, Lukacs J, Smith Y, Zubieta J, Padmanabhan V. Black cohosh treatment induces inverse naloxone responsivity in postmenopausal women: evidence for non-estrogenic neuromodulation. Abstract book, 17th Annual Meeting of the North American Menopause Society, October 11-14, 2006: p. 67.
30. Briese V., Stammwitz U., and Henneicke-von Zepelin H.H. One year treatment with isopropanolic black cohosh extract (iCR). Maturitas 54 (2006) S18
31. Wender M.C., Edelweiss M.I., Campos L.S., de Castro J.A., and Spritzer P.M. Endometrial assessment in women using tibolone or placebo: 1-year randomized trial and 2-year observational study. Menopause 11 (2004) 423-429
32. Neven P., Quail D., Levrier M., et al. Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX study. Obstet Gynecol 103 (2004) 881-891
33. Rymer J., Fogelman I., and Chapman M.G. The incidence of vaginal bleeding with tibolone treatment. Br J Obstet Gynaecol 101 (1994) 53-56
34. Pickar J.H., Yeh I.T., Wheeler J.E., Cunnane M.F., and Speroff L. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: 2-year sub-study results. Fertil Steril 80 (2003) 1234-1240
35. Omodei U., Ferrazzi E., and Ramazzotto F. Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study. Fertil Steril 81 (2004) 1632-1637
36. Mattsson L.A., Skouby S.O., Heikkinen J., Vaheri R., Maenpaa J., and Timonen U. A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen. Climacteric 7 (2004) 59-69
37. Doeren M., Rubig A., Coelingh Bennink H.J., and Holzgreve W. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy. Menopause 6 (1999) 299-306
38. Christodoulakos G.E., Botsis D.S., Lambrinoudaki I.V., et al. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Maturitas 53 4 (2006) 413-423
39. Bennink H.J.T. Are all estrogens the same?. Maturitas 47 (2004) 269-275
40. Kurtay G., Berker B., and Demirel C. Transvaginal ultrasonographic assessment of the endometrium in asymptomatic, postmenopausal women using different HRT regimens containing tibolone or estrogen. J Reprod Med 49 (2004) 893-898
41. Levitzky J., Alli T.A., Wisecarver J., and Sorrell M.F. Fulminant liver failure associated with the use of black cohosh. Dig Dis Sci 50 3 (2005) 538-539
42. Order and Judgement 8: 05 CV 66, Grant and Beck versus Pharmavite LLC. United States District Court for the District of Nebraska. September 8, 2006.
43. Amercian Herbal Products Association. Press Release: U.S. District Court Dismisses Experts and Lawsuit in Black Cohosh Complaint. September 18, 2006.